Topical Insulin Versus Autologous Serum After Corneal Surgeries
Status:
Not yet recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to test whether use of topical insulin or autologous serum eye-drops
can promote corneal epithelial healing following photorefractive keratectomy (PRK).